These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12821498)

  • 1. In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.
    Brooke CJ; Hampson DJ; Riley TV
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2354-7. PubMed ID: 12821498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.
    Wagner J; Jabbusch M; Eisenblätter M; Hahn H; Wendt C; Ignatius R
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2358-61. PubMed ID: 12821499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility testing of Brachyspira intermedia and Brachyspira pilosicoli isolates from Australian chickens.
    Hampson DJ; Stephens CP; Oxberry SL
    Avian Pathol; 2006 Feb; 35(1):12-6. PubMed ID: 16448937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
    Speciale A; Musumeci R; Blandino G; Milazzo I; Caccamo F; Nicoletti G
    Int J Antimicrob Agents; 2002 Feb; 19(2):111-8. PubMed ID: 11850163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial Susceptibility of Pathogenic Gram-positive Anaerobic Cocci: Data of a University Hospital in Turkey].
    Akgül Ö; Söyletir G; Ülger Toprak N
    Mikrobiyol Bul; 2020 Jul; 54(3):404-417. PubMed ID: 32755517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams.
    Behra-Miellet J; Dubreuil L; Jumas-Bilak E
    Int J Antimicrob Agents; 2002 Nov; 20(5):366-74. PubMed ID: 12431872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C; Sabouri S; Nord CE
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):421-5. PubMed ID: 21041506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiamulin resistance in porcine Brachyspira pilosicoli isolates.
    Pringle M; Landén A; Franklin A
    Res Vet Sci; 2006 Feb; 80(1):1-4. PubMed ID: 16253666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
    Tomás I; Tomás M; Alvarez M; Velasco D; Potel C; Limeres J; Diz P
    Oral Microbiol Immunol; 2007 Oct; 22(5):298-303. PubMed ID: 17803626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of DX-619 and four comparator agents against 376 anaerobic bacterial isolates.
    Molitoris D; Väisänen ML; Bolaños M; Finegold SM
    Antimicrob Agents Chemother; 2006 May; 50(5):1887-9. PubMed ID: 16641470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
    Tarasi A; Capone A; Tarasi D; Cassone M; Bianco G; Venditti M
    J Antimicrob Chemother; 1999 Jun; 43(6):833-5. PubMed ID: 10404324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method.
    Ngan CC; Lim T; Choo CM; Toh GL; Lim YS
    Diagn Microbiol Infect Dis; 2004 Mar; 48(3):207-10. PubMed ID: 15023431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
    Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
    Kim JY; Kim NY; Kim SJ; Baik GH; Kim GH; Kim JM; Nam RH; Kim HB; Lee DH; Jung HC; Song IS
    Korean J Gastroenterol; 2011 Apr; 57(4):221-9. PubMed ID: 21519175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
    Ruckdeschel G; Dalhoff A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae.
    Reinert RR; Schlaeger JJ; Lütticken R
    J Antimicrob Chemother; 1998 Dec; 42(6):803-6. PubMed ID: 10052905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of meropenem and other agents against oral bacteria.
    Wade WG; Bishop P
    Chemotherapy; 1992; 38(5):330-4. PubMed ID: 1286575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.